FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

40325811000001101: Gliclazide 160mg tablets (Medihealth (Northern) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Dec 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106581000001112 Gliclazide 160mg tablets (Medihealth (Northern) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106591000001114 Gliclazide 160mg tablets (Medihealth (Northern) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gliclazide 160mg tablets (Medihealth (Northern) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (Medihealth (Northern) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (Medihealth (Northern) Ltd) Is a Gliclazide 160mg tablets true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (Medihealth (Northern) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (Medihealth (Northern) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (Medihealth (Northern) Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (Medihealth (Northern) Ltd) Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (Medihealth (Northern) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Gliclazide 160mg tablets (Medihealth (Northern) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Gliclazide 160mg tablets (Medihealth (Northern) Ltd) 28 tablet Has AMP True Gliclazide 160mg tablets (Medihealth (Northern) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start